Aberrant breakpoints in chronic myelogenous leukaemia; oncogenes and fragile sites Original Investigations DOI:
Cite this article as: Huret, J.L., Tanzer, J. & Henry-Amar, M. Hum Genet (1986) 74: 447. doi:10.1007/BF00280504 Summary
Three hundred and twenty-five aberrant breakpoints in chronic myelogenous leukaemia (CML) with Philadelphia chromosome variant were reviewed. Eight chromosomal bands (3p21, 6p21, 7p22, 11q13, 12p13, 17p13, 17q21, and 17q25) were found to be highly involved. Apart from 17q25, all these bands correspond to oncogenes sites and/or sites involved as primary breakpoints in cancer.
This work was presented in part at the Congrès National d'Hématologie et de Transfusion Sanguine, March 1985 (Nouv Rev Fr Hématol, 1985, 27:72) and at the American Association for Cancer Research Meeting (Proceeding of the AACR 1986, 27:148)
Berger R, Bloomfield CD, Sutherland GR (1985) Report of the Committee on chromosome rearrangements in neoplasia and on fragile sites. (8th International Workshop on Human Genet Mapping) Cytogenet Cell Genet 40:490–535
Mitelman F (1984) Restricted number of chromosomal regions implicated in actiology of human cancer and leukaemia. Nature 310: 325–327
Mitelman E (1985) Catalog of chromosome aberrations in cancer, 2nd edn. (Progress and topics in cytogenetics, vol 5) Liss, New York
Mitelman F (1986) Clustering of breakpoints to specific chromosomal regions in human neoplasia. A survey of 5345 cases. Hereditas 104:113–119